Clinical trial
Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the…
NCT00114790 · Boneca Corporation, Industry · Completed
Key facts
| NCT number | NCT00114790 |
|---|---|
| Title | Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors |
| Official title | Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Inoperable and Irradiated Head and Neck Tumors: A Feasibility Study |
| Lead sponsor | Boneca Corporation, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Radiation |
| Interventions | boronophenylalanine-based BNCT |
| Enrollment | 30 |
| Start date | Dec 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Jan 1, 2012 |
| First posted | Jun 20, 2005 |
| Last update posted | May 6, 2013 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: